Evaluating a quality improvement learning collaborative: qualitative evaluation of Using Labs Wisely Authors: Andrea M Patey, Varunaavee Sivashanmugathas, Gillian Hurwitz, Adina Weinerman, Janet Simons, Wendy Levinson Published: 2026 ABSTRACT AbstractBackgroundOveruse of low-value laboratory tests can harm patients, waste healthcare resources and contribute to environmental damage. To address this, Choosing Wisely Canada launched Using Labs Wisely (ULW), a national learning collaborative designed to reduce unnecessary testing through shared data, training and quality improvement initiatives. ULW brought together hospitals of all sizes to implement stewardship projects, foster collaboration and monitor progress through a centralised data repository. This study evaluated ULW to identify successes, challenges and opportunities for improvement.MethodsWe conducted a qualitative study using a theory-informed interview guide based on the Theoretical Framework of Acceptability (TFA). Fifteen hospitals in the first ULW cohort were invited to participate. Interviews with clinicians and managers explored experiences with ULW, including what worked, what did not and recommendations for improvement. Transcripts were analysed inductively using thematic analysis, with themes reviewed collaboratively and mapped to TFA constructs.ResultsThirteen hospitals participated, reflecting strong interest in reducing low-value testing and valuing ULW’s structured, collaborative approach. Participants highlighted the programme’s national credibility, resources and peer learning opportunities which facilitated institutional buy-in and elevated the laboratory’s role in quality improvement. While generally manageable, common challenges included difficulties with data extraction, lack of standardisation across systems and limited human resources, particularly during pandemic-related strain. Participants called for expanded quality improvement training, clinical outcome tracking and cross-site collaboration to address increasingly complex and costly tests.ConclusionsULW successfully supported hospitals to reduce low-value laboratory testing through structured improvement, benchmarking and peer learning. Challenges remain, particularly around data and resources, but the evaluation highlights key enablers and lessons that can inform the programme’s evolution and guide future collaboratives in other healthcare settings. WHAT IS ALREADY KNOWN ON THIS TOPIC Low-value laboratory testing is a persistent and harmful problem, despite international stewardship initiatives (eg, Choosing Wisely) and sustainable implementation strategies remain difficult to operationalise at scale. Low-value laboratory testing is a persistent and harmful problem, despite international stewardship initiatives (eg, Choosing Wisely) and sustainable implementation strategies remain difficult to operationalise at scale. WHAT THIS STUDY ADDS This study provides the first qualitative evaluation of Using Labs Wisely, a national Canadian learning collaborative, identifying core enablers of success such as national credibility, structured quality improvement (QI) support, peer learning and greater laboratory engagement in institutional QI. This study provides the first qualitative evaluation of Using Labs Wisely, a national Canadian learning collaborative, identifying core enablers of success such as national credibility, structured quality improvement (QI) support, peer learning and greater laboratory engagement in institutional QI. HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY Significant implementation challenges remain, including heterogeneity in data systems, difficulties with data extraction and benchmarking and limited human resource capacity across sites. Significant implementation challenges remain, including heterogeneity in data systems, difficulties with data extraction and benchmarking and limited human resource capacity across sites. Findings inform future practice, policy and research, demonstrating the feasibility of a national learning collaborative for laboratory stewardship, highlighting infrastructure and training needs to support scale-up and outlining priorities for future evaluation of clinical and cost outcomes. Findings inform future practice, policy and research, demonstrating the feasibility of a national learning collaborative for laboratory stewardship, highlighting infrastructure and training needs to support scale-up and outlining priorities for future evaluation of clinical and cost outcomes. Introduction Laboratory tests are frequently overused when they are not clinically indicated.1 2 A meta-synthesis of 42 global studies involving over 1.6 million test results found that 16–25% of laboratory tests ordered were not clinically indicated.2 A synthesis of Canadian studies found that, on average, 19% of laboratory tests were ordered inappropriately, with overuse rates for specific tests—such as complete blood count, prothrombin time, partial thromboplastin time and metabolic panels—reaching as high as 63.2%.3 Overuse of testing can harm patients in several ways, including unnecessary phlebotomies, pain, delays in receiving appropriate tests, false positives leading to misdiagnoses and a cascade of potentially invasive follow-up procedures that increase the risk of overdiagnosis and inappropriate treatments with adverse effects.1 4 5 Overuse in laboratory medicine can also waste valuable healthcare resources.1 5 6 This was never more evident than during the covid pandemic when Healthcare providers (HCPs) around the world experienced a global shortage of test collection tubes for blood tests.7 8 Improving the appropriateness of laboratory testing is now recognised as a critical aspect of clinical laboratories’ quality improvement (QI) efforts.1 2 Choosing Wisely Canada (CWC), the national voice for reducing unnecessary tests and treatments in healthcare, engages with healthcare organisations and professionals to reduce unnecessary tests, treatments and procedures.9 10 To tackle the overuse of laboratory tests in hospitals, CWC developed a national QI learning collaborative whereby hospitals across Canada joined a concerted effort to curb low value testing, so that available laboratory resources could be put to better use.11 QI collaboratives are organised, multifaceted approaches that include teams from multiple healthcare sites coming together to learn, apply and share improvement methods, ideas and data on service performance for a given healthcare topic.12 The use of QI collaborations has shown to improve targeted clinical processes and patient outcomes.13 A recent systematic review reported that participation in QI collaborative activities may improve health professionals’ knowledge, problem-solving skills and attitude; teamwork; shared leadership and habits for improvement.12 It is hypothesised that interactions across QI teams generate normative pressure and opportunities for capacity building and peer recognition.12 13 Using Labs Wisely (ULW), a national consortium of hospitals committed to making a measurable impact on reducing low-value laboratory testing in Canada, was launched in 2022.11 Hospitals of various sizes and levels of experience with implementing laboratory stewardship projects were invited to join ULW. The aim of ULW was to implement change in a laboratory focus area, share aggregated utilisation data on a set list of laboratory tests and attend interactive training webinars with clinicians, laboratory technologists, hospital administrators and researchers from across Canada. Details of ULW can be found in table 1. Briefly, the collaborative comprises three components: (1) a practice community, fostering relationships between laboratory medicine professionals and clinicians in a group learning and sharing environment, (2) a data repository into which members submit and share data for regional comparison and measure of implementation effectiveness and sustainability and (3) the implementation of hospital-set QI laboratory stewardship initiatives (including goal-setting and outcomes in an annual QI plan). The first cohort of participating hospitals joined the learning collaborative in February 2022, with subsequent groups joining September 2022, April 2023 and January 2024. After January 2024, the programme moved to a rolling admission model. Table 1Using Labs Wisely programme characteristics, benefits and expectations*Characteristics Implement change Identify local improvement priorities and develop annual quality improvement plans.Implement interventions to reduce laboratory utilisation and measure the change using the PDSA (Plan-Do-Study-Act) cycle.25 Share data Submit aggregated utilisation data on a defined set of tests.Receive comparative reports on your hospital’s performance compared with peers in the programme.Contribute to the creation of a national reporting system for appropriate laboratory utilisation in Canada. Learn with others Participate in interactive learning sessions with hospitals from across Canada.Gain access to tools, coaching and mentoring opportunities.Network with like-minded clinicians, laboratory experts, researchers and administrators Benefits Participation in Using Labs Wisely allows you to review your local laboratory data against national comparators.Learn and plan quality improvement initiatives proven to reduce unnecessary laboratory testing and qualify for a ‘Using Labs Wisely’ designation.Participate in a learning community on how to improve laboratory resource performance.Share and help set improvement targets for unnecessary laboratory tests and learn how to implement interventions to achieve these new targets.Improve your laboratory resource use. Expectations Hospitals are expected to: Make a commitment from upper hospital leadership to actively participate in the Using Labs Wisely initiative by signing a participation agreement acknowledging ability and willingness to meet the expectations when joining Using Labs Wisely.Nominate and provide the contact details of a laboratory medicine lead and a quality lead/clinical lead, with one also designated as the data lead.Role of laboratory medicine lead: main liaison between Using Labs Wisely and the member hospital lab.Role of quality lead/clinical lead: main liaison between Using Labs Wisely and clinicians/quality improvement department.Role of data lead: person(s) responsible for the data submissions.Extract and transfer laboratory data on a biannual basis for at least 1 year.Respond to any data quality issues in a timely manner and modify data submissions.Have representatives from the member’s organisation participate in routine Using Labs Wisely monthly webinars.Develop and submit an annual QIP to CWC.Carry out improvement initiatives based on QIP and lessons learnt in webinars.If identified as a high performer by the CWC, be willing to share lessons learnt with other members.Permit CWC to use your name and logo to identify you as a member of this programme. Year 1 successOn successful completion of a 1 year cycle of the Using Labs Wisely collaborative:Site will be designated as a Using Labs Wisely hospital and recognised nationally on CWC website.Site will earn two credits toward CWC’s Hospital Designation programme.*Information provided by CWC.CWC, Choosing Wisely Canada; QIP, Quality Improvement Plan. Using Labs Wisely programme characteristics, benefits and expectations* Identify local improvement priorities and develop annual quality improvement plans. Identify local improvement priorities and develop annual quality improvement plans. Implement interventions to reduce laboratory utilisation and measure the change using the PDSA (Plan-Do-Study-Act) cycle.25 Implement interventions to reduce laboratory utilisation and measure the change using the PDSA (Plan-Do-Study-Act) cycle.25 Submit aggregated utilisation data on a defined set of tests. Submit aggregated utilisation data on a defined set of tests. Receive comparative reports on your hospital’s performance compared with peers in the programme. Receive comparative reports on your hospital’s performance compared with peers in the programme. Contribute to the creation of a national reporting system for appropriate laboratory utilisation in Canada. Contribute to the creation of a national reporting system for appropriate laboratory utilisation in Canada. Participate in interactive learning sessions with hospitals from across Canada. Participate in interactive learning sessions with hospitals from across Canada. Gain access to tools, coaching and mentoring opportunities. Gain access to tools, coaching and mentoring opportunities. Network with like-minded clinicians, laboratory experts, researchers and administrators Network with like-minded clinicians, laboratory experts, researchers and administrators Participation in Using Labs Wisely allows you to review your local laboratory data against national comparators. Participation in Using Labs Wisely allows you to review your local laboratory data against national comparators. Learn and plan quality improvement initiatives proven to reduce unnecessary laboratory testing and qualify for a ‘Using Labs Wisely’ designation. Learn and plan quality improvement initiatives proven to reduce unnecessary laboratory testing and qualify for a ‘Using Labs Wisely’ designation. Participate in a learning community on how to improve laboratory resource performance. Participate in a learning community on how to improve laboratory resource performance. Share and help set improvement targets for unnecessary laboratory tests and learn how to implement interventions to achieve these new targets. Share and help set improvement targets for unnecessary laboratory tests and learn how to implement interventions to achieve these new targets. Improve your laboratory resource use. Improve your laboratory resource use. Make a commitment from upper hospital leadership to actively participate in the Using Labs Wisely initiative by signing a participation agreement acknowledging ability and willingness to meet the expectations when joining Using Labs Wisely. Make a commitment from upper hospital leadership to actively participate in the Using Labs Wisely initiative by signing a participation agreement acknowledging ability and willingness to meet the expectations when joining Using Labs Wisely. Nominate and provide the contact details of a laboratory medicine lead and a quality lead/clinical lead, with one also designated as the data lead.Role of laboratory medicine lead: main liaison between Using Labs Wisely and the member hospital lab.Role of quality lead/clinical lead: main liaison between Using Labs Wisely and clinicians/quality improvement department.Role of data lead: person(s) responsible for the data submissions.Extract and transfer laboratory data on a biannual basis for at least 1 year.Respond to any data quality issues in a timely manner and modify data submissions. Nominate and provide the contact details of a laboratory medicine lead and a quality lead/clinical lead, with one also designated as the data lead. Role of laboratory medicine lead: main liaison between Using Labs Wisely and the member hospital lab. Role of laboratory medicine lead: main liaison between Using Labs Wisely and the member hospital lab. Role of quality lead/clinical lead: main liaison between Using Labs Wisely and clinicians/quality improvement department. Role of quality lead/clinical lead: main liaison between Using Labs Wisely and clinicians/quality improvement department. Role of data lead: person(s) responsible for the data submissions.Extract and transfer laboratory data on a biannual basis for at least 1 year.Respond to any data quality issues in a timely manner and modify data submissions. Role of data lead: person(s) responsible for the data submissions. Extract and transfer laboratory data on a biannual basis for at least 1 year. Extract and transfer laboratory data on a biannual basis for at least 1 year. Respond to any data quality issues in a timely manner and modify data submissions. Respond to any data quality issues in a timely manner and modify data submissions. Have representatives from the member’s organisation participate in routine Using Labs Wisely monthly webinars. Have representatives from the member’s organisation participate in routine Using Labs Wisely monthly webinars. Develop and submit an annual QIP to CWC. Develop and submit an annual QIP to CWC. Carry out improvement initiatives based on QIP and lessons learnt in webinars. Carry out improvement initiatives based on QIP and lessons learnt in webinars. If identified as a high performer by the CWC, be willing to share lessons learnt with other members. If identified as a high performer by the CWC, be willing to share lessons learnt with other members. Permit CWC to use your name and logo to identify you as a member of this programme. Permit CWC to use your name and logo to identify you as a member of this programme. Site will be designated as a Using Labs Wisely hospital and recognised nationally on CWC website. Site will be designated as a Using Labs Wisely hospital and recognised nationally on CWC website. Site will earn two credits toward CWC’s Hospital Designation programme. Site will earn two credits toward CWC’s Hospital Designation programme. Information provided by CWC. CWC, Choosing Wisely Canada; QIP, Quality Improvement Plan. We conducted a qualitative evaluation of the ULW programme to understand participating hospitals’ perceptions of ULW, including the contextual factors that influenced implementation, barriers and enablers to change, and the perceived impact of the programme on clinical practice and laboratory utilisation. Findings from this evaluation could help guide other organisations interested in developing learning collaboratives in their settings by learning from the ULW participants’ experiences. The proposed study aimed to understand the successes, challenges and opportunities for improvement of the ULW initiative, including what worked, what did not and how to improve. Methods We conducted a qualitative investigation using a theory informed interview guide with the first cohort of participating clinicians and managers of the CWC ULW learning collaborative (see online supplemental file for interview guide for interview question). We used the Theoretical Framework of Acceptability (TFA)14 to guide the interview. Theoretical underpinnings The TFA is a conceptual model used to evaluate how individuals or groups perceive and embrace a particular innovation, policy, technology or intervention.14 It considers multiple dimensions, such as perceived effectiveness, ethicality, feasibility and user experience, to determine whether something is deemed acceptable by its intended audience (see table 2). This framework is commonly applied in fields like healthcare, education and technology adoption to assess the likelihood of successful implementation and long-term engagement.1518 Table 2Theoretical Framework of Acceptability from Sekhon et al14Affective attitudeHow an individual feels about the interventionBurdenThe perceived amount of effort that is required to participate in the interventionEthicalityThe extent to which the intervention has good fit with an individual’s value systemIntervention coherenceThe extent to which the participant understands the intervention and how it worksOpportunity costsThe extent to which benefits, profits or values must be given up to engage in the interventionPerceived effectivenessThe extent to which the intervention is perceived as likely to achieve its purposeSelf-efficacyThe participant’s confidence that they can perform the behaviour(s) required to participate in the intervention Theoretical Framework of Acceptability from Sekhon et al14 Study setting In Canadian healthcare and academic institutions, clinical and diagnostic laboratories are commonly organised as distinct departments, separate from other clinical services, reflecting their specialised technical, regulatory and quality-assurance requirements. Most laboratories operate within a dyad leadership model, pairing scientific or medical leadership (eg, a medical or scientific director) with operational or administrative leadership arms to jointly oversee clinical quality, workforce management and system performance. Personnel involved in laboratory medicine can be broadly categorised into three groups: (1) Laboratory physicians and/or scientists who are laboratory interest-holders that are typically under the administrative leadership arm; (2) Laboratory directors and/or managers are laboratory interest-holders that are typically under the operational arm; and (3) Clinicians are interest-holders that are typically patient-facing and do not belong to the laboratory medicine group. This leadership structure is intended to integrate professional expertise with organisational accountability and is widely used across hospital-based, regional and academic laboratory systems in Canada. Participants and data collection Representatives from all hospital sites in the initial cohort (n=15) were invited via email to participate in an interview with an experienced female team member (REDACTED) followed by a follow-up email. Interviews were conducted at a date and time that was convenient to the interviewee over the telephone or via Zoom. Participants were asked questions about their experience in the ULW Programme. Briefly, the interview questions asked if the ULW initiative was useful, good use of their time and if it led to hospital change. Additionally, participating leads were asked to identify what worked, what did not work and ways of improving the ULW programme for subsequent cohorts. Data analysis Interviews were audio-recorded, transcribed verbatim, entered in NVivo (V.10.0),19 and were coded inductively using thematic analysis.20 Specifically, one team member (VS) read through the interview transcripts for accuracy and to become familiar with the data. Codes and themes were developed directly from the raw data itself, allowing the identification of new insights and concepts to occur organically without relying on pre-established categories. Themes were reviewed by two other team members experienced with ULW and qualitative analysis (GH, AMP), and discussed until consensus was reached. Themes related to the constructs from the TFA were noted. Results 13 of the 15 participating hospitals (16 leads from 13 sites) from 5 Canadian provinces were interviewed about their experience participating in ULW; two site leads were lost to follow-up. Nine identified as women; seven identified as men. Most participants were laboratory directors/managers (n=9) or laboratory physicians/scientists (n=5). The remaining (n=2) were hospital clinicians. The interviews lasted from 30 to 45 min and themes identified from the interview primarily focus on (1) initial interest in and understanding of ULW, (2) benefits of participation, (3) challenges to programme delivery and potential success, (4) potential resources. Initial interest in and understanding of ULW The majority of participants indicated that their hospitals were very keen on the concept of reducing unnecessary laboratory testing or had even been implementing laboratory utilisation initiatives. The participants reported that the ULW programme effectively fostered collaboration and shared learning by sharing best practices, data and QI strategies (TFA-intervention coherence). How I’ve seen it over these past 2 years as a participant site, I think it’s still in its infancy, but what it has allowed us to do is have almost like an official network of institutions across Canada. – P1, Laboratory director/manager According to participants, ULW fit very well with hospitals’ interests and priorities, provided more structure to QI projects and created momentum to drive the initiatives forward. The participants also reported that because they had roles within their respective hospitals related to QI (ie, director of quality), their organisations encouraged participation in ULW as part of their position deliverables. Many of the hospitals were further incentivised by the integration of ULW into CWC’s Hospital Designation Programme (TFA—Opportunity cost). The main reason our group was interested in attaining the hospital designation for Choosing Wisely Canada…it seemed like a sort of a nice fit for some of our efforts – P3, Laboratory director/manager Participants also reported that networking with like-minded professionals and learning about the inner workings of hospital labs were appealing aspects of ULW (TFA—Affective Attitude). To me, […] we do our own thing, but then using labs wisely brings us all together from what I’ve seen. We learn from each other, and I think it is important for us to know what works, what doesn’t work from other hospitals. We feel like we are working as a team, as a group instead of like working in a silo. – P2, Laboratory physician/scientist Benefits of participation The opportunity to learn from other hospitals, how they were implementing removal of low-value tests, the barriers they faced and how they overcame challenges were important benefits mentioned by multiple sites. Participants based primarily in labs (eg, laboratory manager, clinical biochemist) also reported that highlighting laboratories as a space for innovation and QI initiatives was a novel and great idea. They reported that while hospital labs are a crucial part of patient care, these processes often occur in the background. ULW brought labs to the forefront and set an example of how labs can lead change. I think lab utilization is a great way for lab scientists to connect and interact with clinicians. Labs can often seem mysterious to clinicians, and unless there is intentional effort, the lab is frequently overlooked as a space for collaboration or developing new initiatives within an institution. – P15, Laboratory director/manager From that perspective, focusing on lab utilization provides valuable exposure for the lab. It allows us to advocate for what we can contribute, generate new ideas, and find innovative ways to improve quality within the institution. – P4, Laboratory physician/scientist Additionally, participants reported that CWC’s credibility in leading the ULW national initiative made it easier to get ‘buy-in’ from the hospital, including clinicians. I often suggest ideas and then take them to the clinical team. But I think when the idea comes from me, it carries less weight than if it came from Choosing Wisely. – P6, Laboratory physician/scientist The majority of participants reported that their involvement in ULW did not require substantial sacrifices or compromise of other priorities (TFA—Opportunity Cost). Some noted that their existing roles already aligned with the initiative, making participation a natural fit, while others acknowledged that in different settings, the time commitment might have been more challenging. Ultimately, ULW was perceived as valuable and provided structure, rigour and useful resources that justified the time investment (TFA—Opportunity Cost). Barriers to success While some found it relatively easy due to established data systems and team collaboration, others faced challenges in data extraction and submission, making it more time-consuming (TFA—Burden). The one extra bit of effort it created at times was having to put our QI project information into yet another format. To me, that felt like extra work that didn’t really add much value. I’d send an email to one person, and they wouldn’t receive it. Then I’d get a follow-up email saying I hadn’t provided the information. So I’d have to go back, dig through my emails, and show that I had actually sent it. It was that kind of communication challenge – P6, Laboratory physician/scientist The extent to which barriers affected the success of ULW projects seemed to vary depending on the size of the hospital and whether it was an academic or community site. For example, some participants reported having help from decision support teams or informatics specialists to assist with extracting and submitting data; other participants had to pull the data on their own, which was difficult and time-consuming. Further, while not a direct component of ULW, participants indicated that the different hospital electronic laboratory information systems led to different data being used for reporting to ULW. Subsequently, participants reported challenges when comparing data across participating hospitals. Across participants interviewed, limitations in human resources (eg, administrative support, stakeholder availability) were consistently identified as a critical barrier to progress. Another issue I’ve mentioned in Choosing Wisely discussions is that sometimes people are on the committee only in name — they don’t show up to meetings, or if they do, their cameras are off and they don’t participate. Meanwhile, others are fully engaged, with cameras on and actively contributing. – P16, Clinician This barrier was further exacerbated by the pandemic and burnout reportedly faced by all healthcare staff; laboratory stewardship projects that were based in the emergency department particularly suffered from the lack of staff availability. That continues to be a problem. Nothing has really changed, even post-COVID. The burnout is still there. – P13, Laboratory director/manager Finally, participants reported that colleagues (most commonly clinicians) were often resistant to change. The challenge of getting patient-facing physicians to change ingrained patterns of practice was especially evident at hospitals that lacked physician champions. According to laboratory-based leads at these sites, it often took significant time and multiple conversations to bring clinicians on board with ULW projects. The main barrier in our institution was getting a group of patient-facing clinicians to agree to participate in a committee. – P14, Laboratory director/manager From my perspective, as more of a lab person, I didn’t know many clinicians personally. If I had tried to reach out on my own, it would have felt like cold-calling or sending emails that rarely get responses. So, that was a major challenge. – P7, Laboratory director/manager Conversely, hospitals with physician site leads in place from the outset reported fewer challenges engaging clinical staff and facilitating clinical engagement at their organisation. Programme delivery All participants reported that the ULW comparative reports, whereby participating hospitals received a report which compared rates of laboratory tests targeted in the ULW among the hospitals, were valuable products. These reports were seen as powerful tools to demonstrate to hospitals what needed to be changed in terms of laboratory utilisation. Actually, have you seen the report that we basically compare ourselves across many, many other hospitals… I think that report is very helpful. So for me to bring this report up to the [hospital directors] … to review, right? This is our performance. We already think that we do well. But can we do better, right? – P12, Laboratory director/manager Participants noted that providing benchmarks within these reports would be very helpful because benchmarking would provide a specific target on which to focus, making the reports actionable. Accessibility to recorded webinars, the various toolkits and reference documents for tips for success, overcoming barriers, and implementing utilisation goals, provided by the ULW programme were also appreciated by the participants. There was a reported request for more of these toolkits from sites which had successfully completed projects. The good thing about it is that is the session always recorded, right? […] and then if I cannot make it, I have a resource, slides, the video, things like that. I think Using Labs Wisely have done an amazing job in that sharing information. – P7, Laboratory director/manager Although ULW’s webinars require participants to take out time from their busy schedules, they were viewed as a worthwhile investment of their time. I think monthly is good because it keeps it kind of on your priority list and sort of keeps you accountable to it [….] Did I always have time for a monthly two hour meeting? No, but it kind of makes sense. I think if you’re committed to the project and doing it, then you kind of make it work. – P8, Laboratory physician/scientist So, if it’s just to check in and see how things are going, it might be better to do it less frequently — maybe some bursts of activity during new initiatives and more spaced-out maintenance checks. – P9, Laboratory director/manager Participants enjoyed learning about what other sites were doing and appreciated the teaching sessions. The breakout sessions too I found very useful, because it was good to come together as a whole group and using a lot of wisely could say, here’s what’s going on, here’s our direction, here’s what we need or whatever might be going on for these as wisely, but then we broke up our own individual groups. It was like, how is your project going? What are you doing? Hospital A or up. Here’s what I’m challenges I'm facing anybody else come across this yet and how did you overcome it so…the breakout groups I thought were very beneficial. – P6, Laboratory physician/scientist However, it was felt by some that the webinars may be moving into a ‘maintenance phase’ where there’s less new content and the goal is more so to check in regarding project progress. If this is the case, there were suggestions to reduce the frequency of webinars from once a month to once every 2 or 3 months. I think if you’re in a maintenance phase or looking at new lab tests, like we are, you might want to focus on that and have a few more check-ins while working through it […] But I don’t think doing monthly updates all the time makes much sense unless there’s something particularly new, because it takes time to make changes and do things differently. – P7, Laboratory director/manager If ULW introduced more new content, the participants reported an interest in keeping monthly. Participants were also satisfied with keeping data submission to every 6 months. But I don’t think doing monthly updates all the time makes much sense unless there’s something particularly new, because it takes time to make changes and do things differently. – P3, Laboratory director/manager Potential resources Participants indicated that their hospitals have staff who would be interested in laboratory utilisation projects but do not have QI training. Participants indicated that it would be beneficial for ULW to complement existing tools and training with additional structured QI methodology training or dashboard tools for hospitals to access and build capacity in QI skills. …I really enjoyed the material and the resources just at the ready. It saved me a huge amount of time in research and you know you know it’s just very easy to take the stuff that you guys have shared and then like use my pro side toolkit and develop my communications and stuff like that. It’s been really good. – P14, Laboratory director/manager While participants emphasised the need for structured QI training, they also expressed strong interest in peer-to-peer learning and valued the opportunity to draw on documented successes from other hospitals. A resource that provided a national overview of the ULW projects so that they were able to learn from progress made across the country was suggested. Even something simple, like a “how-to” guide or a list of departments to engage with, along with tips on what to watch for when pulling data, would be very helpful. – P5, Laboratory physician/scientist Lastly, participants inquired if CWC could develop strategies to measure clinical/patient outcomes from implementing ULW principles which would be helpful for convincing frontline physicians to support ULW efforts. Discussion This study aimed to evaluate a QI learning collaborative focused on reducing low-value laboratory testing within hospitals. Our findings contribute to the growing literature on QI learning collaboratives by highlighting the unique structural and operational features of ULW in the Canadian context. One of the critical benefits of the ULW learning collaborative was the structured approach provided to existing QI initiatives. The programme helped formalised pathways for reducing unnecessary tests for hospitals already invested in laboratory stewardship and provided access to shared learning resources. Fostering collaboration and comparison within the dashboard was highly valued, as participants could compare their utilisation patterns with other hospitals, identify areas for improvement and implement evidence-based strategies. The national credibility of CWC played a crucial role in engaging key interest-holders, particularly clinicians, and facilitated meaningful conversations around laboratory stewardship. Traditionally operating in the background, labs were brought to the forefront as spaces for innovation and QI efforts. This increased recognition secures institutional support and establishes laboratory utilisation as a priority within their hospitals. There were also several identified challenges for hospitals. Larger hospitals with established informatics support found this process more manageable, but smaller hospitals struggled with manual data collection, which increased the burden on site leads. In addition, hospitals that had physician champions within their ULW teams found it easier to gain buy-in. Our findings also highlighted the need for strategic resource allocation and administrative support for future laboratory stewardship initiatives. While some sites faced challenges in scheduling and prioritisation, most participants felt that the value of the learning collaborative justified the effort required. In comparison to other learning collaboratives, ULW is narrower in scope but deeper in specificity than most other national learning collaboratives. It leverages a clear de-implementation mandate, custom-designed indicators and a pan-Canadian shared learning network with focused QI coaching. Unlike broader collaboratives such as Safer Healthcare Now!,21 National Health Service Collaboratives related to mental health22 and broad safety,23 or the National Surgical Quality Improvement Program,24 which span multiple clinical domains and often emphasise general safety or outcome improvements, ULW is narrowly concentrated on diagnostic laboratory stewardship (see table 3 for description of three programmes). This specificity enables more targeted measurement, goal-setting and intervention design. Led by CWC and facilitated by healthcare providers who are experts in QI, ULW leverages evidence-informed recommendations, standardised test-use indicators and real-time hospital benchmarking to support practice change. A defining feature of the initiative is its structured use of Plan-Do-Study-Act cycles,25 delivered within a time-bound, cohort-based model supported by centralised coaching and peer-learning infrastructure. In contrast to collaboratives that emphasise capacity-building across varied topics, ULW’s emphasis on de-implementation and resource stewardship distinguishes it as a model for condition-specific or behaviour-specific learning networks. These findings suggest that more narrowly focused collaboratives, when well-supported by data infrastructure and implementation coaching, may be particularly useful in promoting activities to target practice and engage healthcare providers. Table 3Characteristics of ULW versus other national collaborativesCharacteristicULW (Using Labs Wisely)Other national collaboratives (eg, SHN, NSQuIP, NHS)Targeted focusHighly specific: overuse of routine and low-value laboratory testsOften broad (eg, patient safety, surgical outcomes, system redesign)FoundationBuilt explicitly on Choosing Wisely Canada recommendationsMay use guidelines but less tightly linked to national de-implementation campaignsDomainFocuses on clinical laboratory medicine and test ordering behaviourFocuses on safety events (eg, infections, falls), surgeries or mental healthData strategyCustom national laboratory test indicators, real-time benchmarking, shared dashboardsOften uses standard outcome metrics or externally mandated datasets (eg, NSQIP)Learning cyclesStructured PDSA cycles centred on iterative laboratory testing changesMay include PDSA but often broader or more policy-drivenStewardship lensEmphasises health system resource optimisation and demand reductionMany others focus on harm reduction, safety or patient outcomesParticipant diversityIncludes community and academic hospitals across all Canadian provincesOften focused on larger hospitals or specific sectors (eg, surgery, mental health)Implementation supportNational coaching, data literacy support and peer-sharing via Choosing WiselySupport varies; some provide intensive facilitation (eg, NSQIP), others more passiveTime-boundShort, defined collaborative periods (eg, 12–18 months per cohort)Some collaboratives are ongoing or less time-structuredKnowledge productsProduces comparative data reports, implementation tools and indicator guidesOther collaboratives may focus on high-level toolkits or academic evaluationNHS, National Health Service; NSQIP, National Surgical Quality Improvement Program; PDSA, Plan-Do-Study-Act; SHN, Safer Healthcare Now. Characteristics of ULW versus other national collaboratives NHS, National Health Service; NSQIP, National Surgical Quality Improvement Program; PDSA, Plan-Do-Study-Act; SHN, Safer Healthcare Now. While our investigation contributes to the cumulative knowledge related to the usefulness and value of QI learning collaboratives and illustrated the unique features of the ULW programme, there were limitations to our investigation. First, not all hospitals in the first cohort were interviewed. The reason two hospital organisations did not participate in our study is not clear and they may have differing opinions and experiences, perhaps potentially negative, from those we did interview. Second, we only recruited the first cohort of hospitals, a small proportion of the currently enrolled hospitals. However, our rationale was to evaluate the experiences of the first group of ULW hospital site leads and the original format of the ULW collaborative. Since its inception, ULW has evolved and adapted to fit the needs of the participating hospitals while maintaining its core components. However, we do acknowledge that as more hospital organisation participate in ULW, their experiences may differ from those of the first cohort and provide additional insights into whether ULW continued to be valuable. Finally, we did not evaluate the effectiveness of ULW in reducing unnecessary laboratory tests. While this was not the goal of our investigation, it is important to determine whether ULW as a learning collaborative did indeed reduce tests. Work continues within ULW and the participating hospitals to evaluate the effectiveness of the ULW collaborative (manuscript in prep). Opportunities for improvement and future directions As of March 2025, 158 hospitals from across seven provinces have participated in ULW. The ongoing enrolment of hospital organisations has provided opportunities for improvements. For example, in late 2023, several ULW sites indicated that they would appreciate national guidance on minimum re-testing intervals for certain overly ordered laboratory tests at their hospitals. Based on this feedback, CWC and Canada’s Drug Agency (CDA; formerly the Canadian Agency for Drugs and Technology in Health) partnered to convene a multidisciplinary panel of experts to provide guidance on the minimum retesting interval for five commonly used laboratory tests.26 Experts systematically evaluated the evidence and reached consensus to produce white paper recommendations to support hospitals participating in ULW, and possibly other hospital and community labs across Canada (18). In 2024, the Canadian Society of Medical Laboratory Scientists launched a cost calculator to help labs measure the impact of tests and identify opportunities to reduce waste (eg, cost, environmental impact, laboratory technologist time).27 28 Since this initiative, two new laboratory-related medical societies, medical biochemistry and medical laboratory science, have endorsed laboratory-related recommendation lists that were published on the CWC website.29 30 While other CWC national initiatives have been evaluated (eg, evaluation of participant engagement in Using Blood Wisely),31 efforts to evaluate the impact of ULW plans—focusing on their development, implementation and data summarising national reach—were not a part of UBW’s planned evaluation. Evaluation of ULW, including development, implementation and data summarising national reach, is currently underway (manuscript in preparation). Opportunities for further collaboration with national organisation, like these with the CDA or medical societies, to develop additional resource supports within the ULW programme should be considered to ensure ULW has the greatest impact. In addition, ULW and CWC aim to be nimble and maintain a proactive approach to laboratory stewardship. Based on feedback from hospital site leads and the healthcare landscape, ULW has expanded its scope to include newer and more complex tests, such as vitamin B12, erythrocyte sedimentation rate and urine cultures. Going forward, the ULW programme will need to continue to pivot when necessary to meet participating hospitals’ needs as the healthcare laboratory landscape across Canada evolves. Conclusion Our evaluation of the ULW learning collaborative has provided evidence-based insights to inform the development of similar initiatives in other organisations and countries. We have identified key best practices, common challenges and effective strategies for fostering collaboration, knowledge sharing and continuous improvement associated with shared learning models. By identifying what worked well and what obstacles arose, we have provided a foundation for organisations to tailor their approaches to better meet their specific needs to optimise engagement, knowledge dissemination and continuous improvement processes. Furthermore, documented lessons learnt can contribute to the broader evidence base on learning collaboratives, supporting the replication and adaptation of effective models across diverse contexts. Supplementary material